Sudan virus, a close relative of Ebola, has a fatal rate of 50%, but is poorly understood in terms of how to infect cells. Currently, no approved treatment exists. To address this significant difference in the preparation of epidemic, the University of Minnesota, and the Midwest Antiviral Drug Discovery (AVIDD) Center examined how the deadly virus connects to human cells.
